跳至主要内容
临床试验/CTRI/2025/12/098954
CTRI/2025/12/098954尚未招募4 期

A PROSPECTIVE STUDY TO COMPARE THE CLINICAL EFFICACY OF PROBIOTICS AS AN ADJUVANT TO STANDARD THERAPY IN A PATIENTS WITH MILD-MODERATE BRONCHIAL ASTHMA IN A TERTIARY CARE CENTRE IN SOUTH INDIA

PREETHI S1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年12月27日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
80
试验地点
1

研究概览

简要总结

Patients with clinically confirmed bronchial asthma as per GINA criteria 2023 are enrolled in this study.

Enrolled participants will be divided into two groups a) Standard therapy for Bronchial asthma, b) Standard therapy with probiotics as adjuvant drugs twice a day, daily for 8weeks

Participants will be followed up after 2weeks, 4weeks and 8weeks after baseline visit.

All participants will undergo complete blood count as routine investigation, included IgE level and PFT to be calculated and the outcome will be assessed at each visit.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
All

入选标准

  • Male or female patient with age group between 18-45 years.
  • Male or female patient, who met the diagnostic criteria for asthma, with temporarily stable asthmatic symptoms in non-acute attack stage that could be controlled by drug treatment.
  • Patients willing to give written and informed consent.
  • Conscious and co-operative patients.

排除标准

  • Patients not willing to give consent Male or female patient with any history of major disease, such as gastrointestinal diseases, long term requirement for glucocorticoids or other immunosuppressive agents, antibiotics intake 1 month before the trial.

研究者

发起方
PREETHI S
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

PREETHI S

ACS MEDICAL COLLEGE AND HOSPITAL

研究点 (1)

Loading locations...

相似试验